Literature DB >> 11422650

Breast cancer screening for older women with intellectual disability living in community group homes.

N Davies1, M Duff.   

Abstract

Breast cancer is one of the commonest cancers to affect women. Present health service guidelines call for screening and mammography for all women aged between 50 and 65 years in an effort to increase early detection and improve survival rates. Nulliparity is one of the associated risk factors for breast cancer. Women with intellectual disability (ID) are increasing in longevity and are frequently nulliparous, and therefore, they are at increased risk of developing breast cancer. The aim of the present study was to review the uptake and knowledge of women with ID living in the community of breast screening programmes. A postal survey of women aged > or = 50 years with ID living in community group homes was used to gather data. Only one-third of the women carried out regular breast examination and a similar proportion had received invitations to mammography. General practitioners and practice nurses were currently playing very minor roles in breast screening these women. Primary health care professionals may be missing opportunistic health promotion opportunities and the support services for women with ID living in the community could be provided with better training and resources to improve breast cancer screening in this vulnerable group.

Entities:  

Mesh:

Year:  2001        PMID: 11422650     DOI: 10.1046/j.1365-2788.2001.00313.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  14 in total

Review 1.  Screening tests for adults with intellectual disabilities.

Authors:  Joanne E Wilkinson; Larry Culpepper; Mary Cerreto
Journal:  J Am Board Fam Med       Date:  2007 Jul-Aug       Impact factor: 2.657

2.  Measuring preparedness for mammography in women with intellectual disabilities: a validation study of the Mammography Preparedness Measure.

Authors:  Claire Tienwey Wang; Nechama Greenwood; Laura F White; Joanne Wilkinson
Journal:  J Appl Res Intellect Disabil       Date:  2014-09-30

3.  Determinants of mammography in women with intellectual disabilities.

Authors:  Joanne E Wilkinson; Emily Lauer; Karen M Freund; Amy K Rosen
Journal:  J Am Board Fam Med       Date:  2011 Nov-Dec       Impact factor: 2.657

Review 4.  Access to health care for people with learning disabilities in the UK: mapping the issues and reviewing the evidence.

Authors:  Alison Alborz; Rosalind McNally; Caroline Glendinning
Journal:  J Health Serv Res Policy       Date:  2005-07

5.  'It's easier said than done': perspectives on mammography from women with intellectual disabilities.

Authors:  Joanne E Wilkinson; Cristina E Deis; Deborah J Bowen; Barbara G Bokhour
Journal:  Ann Fam Med       Date:  2011 Mar-Apr       Impact factor: 5.166

6.  Testing the feasibility of a DVD-based intervention to promote preparedness for mammography in women with intellectual disabilities.

Authors:  Nechama W Greenwood; Claire Tienwey Wang; Deborah Bowen; Joanne Wilkinson
Journal:  J Cancer Educ       Date:  2014-03       Impact factor: 2.037

Review 7.  Primary care for women with intellectual disabilities.

Authors:  Joanne E Wilkinson; Mary C Cerreto
Journal:  J Am Board Fam Med       Date:  2008 May-Jun       Impact factor: 2.657

8.  Measuring staff empowerment regarding health care for clients with intellectual disabilities.

Authors:  Joanne Wilkinson; Nechama W Greenwood; Claire Tienwey Wang; Laura F White; Larry Culpepper
Journal:  Int J Family Med       Date:  2014-02-25

Review 9.  Sexual and reproductive health care for women with intellectual disabilities: a primary care perspective.

Authors:  Nechama W Greenwood; Joanne Wilkinson
Journal:  Int J Family Med       Date:  2013-12-12

10.  Age and stage at diagnosis: a hospital series of 11 women with intellectual disability and breast carcinoma.

Authors:  Daniel Satgé; Eric-André Sauleau; William Jacot; Fernand Raffi; Bernard Azéma; Jean-Claude Bouyat; Nicolas El Hage Assaf
Journal:  BMC Cancer       Date:  2014-03-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.